Platinum Sponsor

Beckman Coulter Life Sciences

Beckman Coulter Life Sciences is dedicated to developing and providing advanced technologies and equipment for research and discovery to explore new treatment methods. Our products include Liquid Handling and Genomic solutions, Particle Counting and Characterization, Centrifugation and Flow Cytometry, which are implemented in all major areas of Life Sciences such as biology, biochemistry, biophysics, nanotechnology and molecular biology to simplify and automate existing processes in the lab.

Our vision: Advancing science through discovery

Our mission: Delivering innovative and trusted scientific solutions across the globe


Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California, USA.

Kite, a Gilead Company, is a biopharmaceutical company based in Santa Monica, California, USA. Kite is engaged in the development of innovative cancer immunotherapies. The company is focused on chimeric antigen receptor and T cell receptor engineered cell therapies. For more information, please visit our website.


Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. We consistently rank among the world’s top companies investing in research and development. Novartis products reach more than 800 million people globally and we are continuously searching for innovative ways to expand access to our innovative treatments. About 130 000 people of
nearly 150 nationalities work at Novartis around the globe.

Silver Sponsor


BioNTech Innovative Manufacturing Services GmbH- CDMO FOR CELL AND GENE THERAPY
BIONTECH IMFS is a Contract Development and Manufacturing Organisation specialized in the industrialization of cell and gene therapy products (viral vectors, cells and ivt mRNA). For 20 years, BIONTECH IMFS has been developing and manufacturing retroviral vectors and cellular products for clinical supply in a variety of monogenetic diseases and different cancer indications.

Based on extensive expertise in scientific, technical and regulatory prerequisites, we develop and manufacture your products in a safe and cost-efficient way in our state-of-the-art GMP facility.

We offer a complete service spectrum from process development through clinical trial to in-market supply. All services are fully integrated and supervised by our QA department, ensuring efficient and compliant manufacturing.


Fluidigm Corp creates, manufactures, and markets technologies and life-science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon microfluidics and mass cytometry technologies.


MaxCyte is a global cell-based medicines and life sciences company applying its patented cell engineering technology to help patients with high unmet medical needs in a broad range of conditions. The company leverages its Flow Electroporation® Technology to enable its partners across the biopharmaceutical industry to advance the development of innovative medicines, particularly in cell therapy, including gene editing and immuno-oncology. MaxCyte has placed its cutting-edge flow electroporation instruments worldwide, including with nine of the top 10 global biopharmaceutical companies, and has more than 55 partnered program licenses in cell therapy including more than 25 licensed for clinical use. With its robust delivery technology, MaxCyte helps its partners to unlock the full potential of their products.

Miltenyi Biotec

Miltenyi Biotec is a global provider of products and services that advance biomedical research and cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. Used by scientists and clinicians around the world, our technologies cover techniques of sample preparation, cell isolation, cell sorting, flow cytometry, and cell culture. Our more than 25 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer. Today, Miltenyi Biotec has more than 2,000 employees in 28 countries – all dedicated to helping researchers and clinicians make a greater impact on science and health.


Polyplus Transfection

Polyplus-transfection applies its 15+ year expertise to the development of novel transfection solutions up to GMP grade for high yield transient protein and antibody production in CHO and HEK-293 cells, as well as for viral vector production for Gene and Cell Therapy (PEIpro product range).



Being the largest cell bank in the German-speaking countries, Vita 34 is the expert in storing stem cells collected from the umbilical cord at birth.

Stem cells are already being the basis of numerous medicinal treatments and they will shape the medicine of the future with personalized therapies tailored to individual needs. Since 1997, Vita 34 has been part in making this vision become reality.

Being a full-range supplier with about 100 employees, we provide services ranging from the collection to the processing and preservation to the professional release for application. Over 230,000 customers from more than 20 countries have already taken care of their family’s health by means of a cell deposit with Vita 34.

40 applications so far in treatment attempts, studies, and individual cases put Vita 34 in a top position and prove the excellent quality of its preparations.

We take pride in what have reached. And we take the status quo as our steppingstone for new ideas, services, and products available to everyone.

Bronze Sponsor

Astra Zeneca

AstraZeneca Plc. is a global pharmaceutical company with a major UK presence and is a FTSE 100 company. Our mission is to push the boundaries of science to deliver life-changing medicines and healthcare systems. We are committed to making a meaningful difference to patient health and we believe the best way we can do this is to be led by the translation of science. We are continuously working to make the most of the opportunities that frontier science and technologies bring to the search for new medicine and we share this passion with the scientific, healthcare and business community of the UK. 



Bio-Techne® has united some of the most referenced brands in Life Sciences: R&D Systems®, Novus Biologicals®, Tocris®, ProteinSimple® and Advanced Cell Diagnostics®. Our family of brands collaborate to provide over 50,000 products for Life Science research. We have over 350,000 journal Exhibitor citations, showing that our combined experience is trusted.


Celgene is a global biopharmaceutical company. The Celgene Corporation was founded in 1986 in New Jersey, USA. The company focuses on research, development and commercialization of innovative therapies for the treatment of hematological, oncological and severe immune and inflammatory diseases. Celgene invests more than 30 percent of its annual revenue in research and development activities to help patients live longer, better and more productive lives through new treatment options. For more information, please visit the Celgene GmbH website at

JPT Peptide Technologies

JPT provides products and services for all the development phases of next generation immunotherapeutics. With sound knowledge in immunology and peptide chemistry, we offer peptides and peptide pools (PepMix™) for antigen-specific stimulation of cells, humoral and cellular epitope mapping, viral transduction, and development of immunotherapies. 
Thanks to an enhanced production protocol, our peptides are the product of choice for the development of cell therapies such as adoptive cell transfer or dendritic cell pulsing independent if you are aiming for an individualized neo-epitope approach or working with shared and common antigens. 
With our novel transduction enhancer Protransduzin™ the generation of CAR-Ts or TCR-Ts can be streamlined by enhancement of viral transduction in a simple one-step protocol.  Humoral immune response is addressed with our PepStar™, high-content microarrays for seromarker discovery and multiwell microarrays for profiling up to 20 samples.


With a portfolio of more than 4,000 products covering the fields of genomics, protein analysis and expression, cellular analysis, drug discovery and genetic identity, Promega is a global leader in providing innovative solutions and technical support to life scientists in academic, industrial and government settings.
Promega products are used by life scientists who are asking fundamental questions about biological processes as well as by scientists who are applying scientific knowledge to diagnose and treat diseases, discover new therapeutics, and use genetics and DNA testing for human identification.
Promega holds significant intellectual property rights and licenses in several key areas that form a foundation for its diverse portfolio including:

  • Bioluminescence, including engineered luciferases, luciferase reporter vectors and luciferase substrates
  • Short tandem repeat (STR) detection for STR-based cell line authentication, human identification, cell and tissue characterization, and mixed sample detection
  • HaloTag® protein labeling and capture technology

Originally, founded in 1978 in Madison, Wisconsin, USA, Promega has branches in 16 countries and more than 50 global distributors serving 100 countries. If you are looking for your local Promega sales office, manufacturing facility or product distributor, you can find contact information here.
A cornerstone of Promega business practice is supporting customers, community and employees.

SGS Vitrology

SGS is the world’s leading inspection, verification, testing and certification company. SGS operates a network of over 1,500 offices and laboratories around the world.

The Life Science division serves pharmaceutical, biopharmaceutical, and medical device companies along the entire drug development pathway. With over 35 years’ experience as a global contract service organization, SGS provides integrated (bio)pharmaceutical development and testing solutions including clinical research, pharmaceutical development, biologics characterization, biosafety, and quality control testing for small and large molecules, raw materials, containers and finished products.
SGS Vitrology provides a comprehensive range of biosafety services such as: virology, cell and molecular biology as well as microbiology and electron microscopy. Health Authorities, including the US FDA and the EMA, require companies to undergo safety testing demonstrating that cell banks, viral banks, raw materials, bulk harvests, and batches of clinical drug are free of bacteria, fungi, mycoplasma, viruses and other potential contaminants. SGS Vitrology helps clients by ensuring product safety in satisfying these regulatory requirements. Our GLP/GMP facility is MHRA certified and US FDA audited.